4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-20-017282
President & CEO sold 1,008 shares at $100.44 ($101,244)
- President & CEO acquired 14,510 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Simon, Christopher · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-15 | Sale : show line 1 in the form | −1,008 | $100.44 | $101,244 | 303,757 | D |
| 2020-05-18 | Grant or award : show line 2 in the form | +14,510 | 318,267 | D | ||
| Open-market sales · 1,008 sh · avg $100.44 · $101,244 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-18 | Grant or award : show line 3 in the form Non-qualified Stock Option (Right to Buy) | +49,105 | 49,105 | D |
Loading xslF345X03/form4.xml…